Phase II trial of sequential gefitinib after minor response or partial response to chemotherapy in Chinese patients with advanced non-small-cell lung cancer

BACKGROUND: Basic research of gefitinib (Iressa, ZD1839) has demonstrated the combination effects of gefitinib and chemotherapy were sequence-dependent. To evaluate the efficacy of sequential administration of gefitinib following a minor response or partial response to two to three cycles of chemoth...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Jian Ming, Han, Yu, Li, Yue Min, Zhao, Chuan Hua, Wang, Yan, Paradiso, Angelo
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1764758/
https://www.ncbi.nlm.nih.gov/pubmed/17173694
http://dx.doi.org/10.1186/1471-2407-6-288

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1764758/
https://www.ncbi.nlm.nih.gov/pubmed/17173694
http://dx.doi.org/10.1186/1471-2407-6-288

Ejemplares similares